There is no claim that escitalopram tablets are susceptible to cancer. Escitalopram tablets is a selective 5-hydroxytryptamine reuptake inhibitor, with good and stable antidepressant, anxiolytic, anti-obsessive-compulsive effect, mainly used in the treatment of depression, obsessive-compulsive disorder, generalized anxiety, panic attacks, somatization disorder, neurasthenia and other psychological disorders, but also for the treatment of patients with premature ejaculation. During the administration of escitalopram tablets, the most common adverse reactions are gastrointestinal reactions such as nausea, vomiting, diarrhea, constipation, loss of appetite, etc. Adverse neurological reactions such as insomnia, excessive sweating, drowsiness, mental weakness may also occur. It is forbidden to use it in combination with irreversible monoamine oxidase inhibitors for those who are allergic to the components of the drug and cardiovascular patients. It should be noted that escitalopram tablets are prescription drugs and need to be used under strict medical supervision.